Oral Solid Dose Formulations
iDPC can tailor coatings to modulate dissolution performances either to enhance or delay drug release profiles to deliver a targeted profile, whilst enhancing stability and optimising form manufacture.
APT has extensive experience in solving complex formulation and process development challenges, our experts and proprietary iDPC technology can support your optimisation of lead compounds from pre-formulation up to clinical manufacturing and beyond
Oral Formulations
- Can enhance dissolution and dissolution rate of poorly soluble APIs
- Can control/tailor dissolution to mask taste
- Can modify – accelerate or delay API release profile
